American Journal of Hematology

Journal

Publication Venue For

  • Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient.  95:1117-1120. 2020
  • Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.  95:623-629. 2020
  • Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.  95:662-671. 2020
  • Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS).  95:258-266. 2020
  • Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphoma.  95:18-27. 2020
  • A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.  94:E299-E301. 2019
  • Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.  94:417-423. 2019
  • Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study.  94:200-208. 2019
  • Fat embolism syndrome due to bone marrow necrosis in patients with hemoglobinopathies: A life-threatening complication mimicking thrombotic thrombocytopenic purpura.  94:E64-E66. 2019
  • Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.  94:E27-E29. 2019
  • Acute kidney injury during parvovirus B19-induced transient aplastic crisis in sickle cell disease.  93:E198-E200. 2018
  • Visualization of the bone marrow biopsy needle track.  93:E60-E61. 2018
  • Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults.  93:238-245. 2018
  • Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.  93:E49-E52. 2018
  • Rare complication of treated immune thrombocytopenia.  92:1262-1266. 2017
  • Sickle cells produce functional immune modulators and cytotoxics.  92:981-988. 2017
  • Early mortality and overall survival of acute myeloid leukemia based on facility type.  92:764-771. 2017
  • The association of histologic grade with acute graft-versus-host disease response and outcomes.  92:683-688. 2017
  • Publication outcomes of abstracts from the American Society of Hematology Annual Meeting.  92:E81-E83. 2017
  • Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.  92:161-170. 2017
  • Management of relapsed and refractory multiple myeloma in modern times: Incorporating new agents into decision-making.  91:1044-1051. 2016
  • Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.  91:101-108. 2016
  • Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.  90:1052-1054. 2015
  • Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission.  90:242-249. 2015
  • Seasonal and regional variation of thrombotic thrombocytopenic purpura in the United States: Insights from the Nationwide Inpatient Sample.  90:E24. 2015
  • Peering into the future: Hepcidin testing.  88:976-978. 2013
  • Novel G377S (c.1246G>T) mutation associated with Gaucher disease type 1.  88:922-923. 2013
  • The isolated prolonged PTT.  88:82-85. 2013
  • Multiorgan failure and bone marrow necrosis in three adults with sickle cell-β +-thalassemia.  87:621-624. 2012
  • Effectiveness and safety of high-dose cyclophosphamide as salvage therapy for high-risk multiple myeloma and plasma cell leukemia refractory to new biological agents.  86:699-701. 2011
  • High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.  86:554-558. 2011
  • Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.  86:430-432. 2011
  • Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.  85:627-629. 2010
  • Diagnosis of thrombotic thrombocytopenic purpura with normal ADAMTS13 activity and absence of its inhibitor (anti-ADAMTS13 antibodies).  83:256. 2008
  • Refractory thrombocytopenia and positive platelet crossmatches without HLA or platelet-specific antibodies.  82:175-176. 2007
  • Use of breath carbon monoxide measurements to assess erythrocyte survival in subjets with chronic diseases.  81:432-438. 2006
  • Autoimmune hemolytic anemia in an infant with giant cell hepatitis..  81:199-201. 2006
  • Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.  81:199-201. 2006
  • Acute transient leukopenia as a sign of TRALI [5].  80:90-91. 2005
  • Scurvy: An often forgotten cause of bleeding [2].  74:85-87. 2003
  • Inflammatory mediators promote strong sickle cell adherence to endothelium under venular flow conditions.  73:215-224. 2003
  • Hairy cell leukemia with concurrent cryptococcus infection.  72:223-224. 2003
  • Sickle erythrocyte adherence to endothelium at low shear: Role of shear stress in propagation of vaso-occlusion.  70:216-227. 2002
  • Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura.  69:228-231. 2002
  • Non-anemic homozygous β thalassemia in an african-american family: Association of high fetal hemoglobin levels with β thalassemia alleles.  68:43-50. 2001
  • Molecular basis for Rh(null) syndrome: Identification of three new missense mutations in the Rh50 glycoprotein gene.  62:25-32. 1999
  • Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene..  62:25-32. 1999
  • BFU-E Colony Growth in Response to Hydroxyurea: Correlation between In Vitro and In Vivo Fetal Hemoglobin Induction.  56:252-258. 1997
  • Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides.  53:92-98. 1996
  • Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: An aid in assessing marrow recovery.  46:319-324. 1994
  • Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells.  42:284-292. 1993
  • Regulation of Tissue Plasminogen Activator in Sickle Cell Anemia.  35:167-170. 1990
  • Protein S and C antigen levels in proteinuric patients: Dependence on type of glomerular pathology.  31:96-101. 1989
  • Totally implantable intravenous catheters in the management of sickle cell anemia.  29:134-138. 1988
  • In vitro effects of gammaglobulin (IgG) on human monocyte Fc receptor function. I. Effect on monocyte membrane‐associated IgG and Fc receptor‐dependent binding of antibody‐coated platelets.  23:197-207. 1986
  • International Standard Serial Number (issn)

  • 0361-8609
  • Electronic International Standard Serial Number (eissn)

  • 1096-8652